Navigation Links
U.S. Gives Green Light to Publish Controversial Bird Flu Research
Date:4/23/2012

FRIDAY, April 20 (HealthDay News) -- The U.S. government is giving the go-ahead for publication of two controversial studies into the H5N1 avian (bird) flu virus, a top federal health official announced Friday.

The research, led by two scientists -- Yoshihiro Kawaoka of the University of Wisconsin and Ron Fouchier of Erasmus Medical Center in Rotterdam, the Netherlands -- involved the manipulation of the potentially lethal virus until it was transmissible between ferrets, thought to be a close model for humans. As yet, H5N1 is not easily transmitted between humans.

In December, the Department of Health and Human Services (HHS) requested that two leading journals, Science and Nature, censor some of the data from this research for national security reasons. The concern was that terrorists might use the information to create a biological weapon.

However, on Friday, Dr. Francis Collins, director of the U.S. National Institutes of Health, announced in a statement that full publication could go forward. The decision was based on a March 29-30 meeting of the National Science Advisory Board for Biosecurity (NSABB), an independent panel of experts that advises the federal government on such matters.

According to Collins, "After careful deliberation, the NSABB unanimously recommended the revised manuscript by Dr. Yoshihiro Kawaoka be communicated in full. The NSABB also recommended, in a 12-to-6 decision, that the data, methods, and conclusions presented in the revised manuscript by Dr. Ron Fouchier be communicated fully after a number of further scientific clarifications are made in the manuscript."

Collins added that the research has "direct applicability to ongoing and future influenza surveillance efforts and does not appear to enable direct misuse of the research in ways that would endanger public health or national security."

He said that HHS Secretary Kathleen Sebelius agreed with the decision. "The information in the two manuscripts should be communicated fully and we have conveyed our concurrence to the journals considering publication of the manuscripts," Collins said.

Kathy Wren, a spokeswoman for Science, which is withholding the Fouchier study, said the journal is still waiting for a decision by Dutch regulators next week before deciding when it will publish the research, Bloomberg News reported.

More information

Find out more about H5N1 avian influenza at the U.S. Centers for Disease Control and Prevention.

-- E.J. Mundell

SOURCES: Francis Collins, M.D., PhD, director, U.S. National Institutes of Health, statement, April 20, 2012; Bloomberg News


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Research gives hope to detecting cancer in early stages
2. Electrical pulse treatment gives pancreatic cancer patients new hope
3. Chorus Gives Voice to Those With Alzheimers
4. Dentist Gives Advice to Keep Holiday Smiles Bright
5. Hospital gives first tomosynthesis mammograms in region this week
6. Rare Seizure Disorder Gives Clues About Brains Laughter Center
7. Dr. Albert Rizzo gives Estabrook Lecture on Dec. 2
8. George Mason University research gives hope to women with deadliest breast cancer
9. How major signaling pathways are wired to our genome gives new insight into disease processes
10. New online learning module gives children of domestic violence a voice
11. Bone-strengthening drug gives pain relief in prostate cancer bone metastases
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
U.S. Gives Green Light to Publish Controversial Bird Flu Research
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: ... “America On The Brink” is the creation of published author, William Nowers. ... As a WWII veteran, he spent thirty years in the Navy. Following ...
(Date:10/12/2017)... ... 12, 2017 , ... The company has developed a suite ... regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been developed ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
(Date:10/12/2017)... Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... is holding a treadmill relay – Miles by Moonlight to raise money for the ... donating $300 or more. , Teams will work together to keep their treadmills ...
(Date:10/12/2017)... ... 2017 , ... Vohra Chief Medical Officer Dr. Shark Bird, ... nursing facility medical directors and other clinicians at various events in October. His ... many of these conferences we get to educate other physicians, facility nurses, corporate ...
Breaking Medicine News(10 mins):
(Date:10/5/2017)... 2017  In response to the nationwide opioid ... Surgeons (AAOMS) released prescribing recommendations that urge ibuprofen ... as a first-line therapy to manage a patient,s ... Recognizing the value and importance of ... Prescribing: Acute and Postoperative Pain Management" stresses that ...
(Date:10/2/2017)... -- Eli Lilly and Company (NYSE: LLY ) ... of 2017 on Tuesday, October 24, 2017. Lilly will ... the investment community and media to further detail the ... begin at 9 a.m. Eastern time. Investors, media and ... the conference call through a link that will be ...
(Date:9/28/2017)... 2017 Cohen Veterans Bioscience and Early Signal ... wearable and home sensors for real-time monitoring of patients ... a nonprofit organization focused on disruptive health solutions for ... analytical system to record and integrate behavioral, cognitive, physiological ... ...
Breaking Medicine Technology: